Bedside Bone Health When DXA Isn’t Possible

A Practical, Evidence‑Based Role for Quantitative Ultrasound (QUS)

PART I

Why This Paper Exists

Advanced Imaging Services (AIS) has spent more than three decades delivering diagnostic imaging to patients in rural areas and to those who cannot reasonably access facility‑based care. That experience included a fixed site unit mounted in a mobile DXA van (to include spine and hip services delivered to rural hospitals under AIS’s former OsteoScan division), and large‑scale community screening programs such as Save‑A‑Life Screening.

The reality today is simple: true bedside access to DXA no longer exists for most patients. New portable DXA systems are no longer commercially available, and frail, non‑ambulatory, or institutionalized patients are often unable to travel safely for a scan.

This paper explains why Quantitative Ultrasound (QUS) fills that gap, not as a replacement for DXA in every circumstance, but as a clinically validated method for fracture‑risk assessment and bone health screening when DXA is not feasible.

Osteoporosis Is a Fracture‑Risk Disease — Not Just a Number

DXA has long been used to measure bone mineral density (BMD) and define osteoporosis using WHO T‑score thresholds. That framework remains important. However, decades of clinical data now show a critical limitation: most fragility fractures occur in patients whose DXA BMD does not meet the osteoporosis threshold.

Bone strength is influenced by more than mineral density alone. Architecture, elasticity, and microstructure all contribute to fracture risk, and these properties are not fully captured by areal BMD measurements.

What QUS Measures

Quantitative Ultrasound evaluates bone by measuring how sound waves travel through it, commonly reported as speed of sound (SOS). Unlike X‑ray–based technologies, QUS:

• Uses no ionizing radiation

• Is portable and bedside‑capable

• Is typically performed at peripheral skeletal sites such as the distal radius

QUS provides information related to bone quality and mechanical competence that complements, but is not identical to, DXA‑measured BMD.

What the Evidence Shows

Large population studies and prospective trials demonstrate that QUS measurements:

• Predict fracture risk independently of DXA BMD and clinical risk factors

• Provide meaningful discrimination between fracture and non‑fracture populations

• Capture skeletal information not fully reflected by mineral density alone

In practical terms, QUS identifies patients at increased fracture risk who may otherwise be missed when relying solely on BMD thresholds.

Where QUS Fits Best

QUS is particularly appropriate when:

• The patient is homebound, bedbound, or institutionalized

• Transport to a DXA facility poses medical or logistical risk

• The clinical goal is fracture‑risk stratification or screening

• The result will inform fall‑risk management, care planning, or further evaluation

DXA remains the reference standard for formal osteoporosis diagnosis and for certain guideline‑driven treatment decisions. QUS is best understood as a practical, evidence‑based solution when DXA access is not realistically available.

What AIS Provides

AIS performs bedside peripheral QUS bone assessments, currently measuring SOS at the distal radius. Reports include:

• Speed of sound (m/sec)

• T‑score (young adult reference)

• Z‑score (age‑matched reference)

• Radiologist interpretation

Results are delivered directly to the ordering clinician and integrated into the patient’s overall clinical context.

Coverage and Access

Medicare covers bone mass measurements for qualifying patients. CMS guidance includes ultrasound bone density and QUS within the broader category of bone mass measurement services.

However, coverage does not always equal payment, and bedside services may be subject to payer‑specific rules, plan design, supplier enrollment, and documentation requirements, particularly under Medicare Advantage. For Medicare enrollees, Medicare does not provide a pathway to gain access for Portable Diagnostic Providers to transport or bill the QUS bone density exam at this time.

AIS works with ordering providers and patients to determine the most appropriate and compliant pathway for each situation.

Bottom Line

When DXA is unavailable or impractical, QUS offers a clinically validated, low‑burden, bedside method to assess fracture risk and bone health. It is not a replacement for DXA in all cases, but for many patients, it is the only realistic way to obtain meaningful skeletal information.

Prepared by Advanced Imaging Services (AIS). This document is educational in nature and does not constitute medical advice or billing guidance